NCT03681873: Validation of Low Dose CT for Diagnosis of Lung Nodules

NCT03681873
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Enrolling by invitation
Not Applicable
Drug Category: Other

Key Eligibility Criteria:

Gender: All
Age: 4 Years to 20 Years (Child, Adult)
Location of Metastases: Lung
Additional Notes: Patient must be planning to undergo a clinically indicated CT of the chest
Exclusions: Patients over 20 years of age
https://ClinicalTrials.gov/show/NCT03681873

Comments are closed.

Up ↑